TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17710800

Group type: EXPERIMENTAL
Intervention: Enalapril and yixin jiangya Capsules
Number of subjects: 93

Group type: COMPARATOR
Intervention: Enalapril (Control)
Number of subjects: 93
Study: 15125121

Group type: EXPERIMENTAL
Intervention: 200 IU of nasal salmon calcitonin daily for three months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11246059

Group type: EXPERIMENTAL
Intervention: Multidisciplinary care (MC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 70
Study: 10181020

Group type: EXPERIMENTAL
Intervention: Group B (intervention with classroom program, involvement of parents, and teacher courses)
Number of subjects: 4441

Group type: COMPARATOR
Intervention: Group A (control)
Number of subjects: 4441

Group type: EXPERIMENTAL
Intervention: Group C (intervention without teacher courses)
Number of subjects: 4441

Group type: EXPERIMENTAL
Intervention: Group D (intervention without parental involvement)
Number of subjects: 4441

Group type: EXPERIMENTAL
Intervention: Group B (most extensive intervention) among high-risk students
Number of subjects: 4441
Study: 7512100

Group type: EXPERIMENTAL
Intervention: Alprazolam (6 to 10 mg/day for 43 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 9
Study: 2411026

Group type: EXPERIMENTAL
Intervention: Palliative X-ray irradiation
Number of subjects: 47
Study: 30925783

Group type: EXPERIMENTAL
Intervention: Cycling at an active workstation
Number of subjects: 37
Study: 29714449

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MF) for 4 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Physiologic saline (SP) and desloratadine
Number of subjects: 41
Study: 27333970

Group type: EXPERIMENTAL
Intervention: AP with exercise dosing adjustment (APX)
Number of subjects: 21

Group type: COMPARATOR
Intervention: AP with no exercise dosing adjustment (APN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy (SAP)
Number of subjects: 21
Study: 25042878

Group type: EXPERIMENTAL
Intervention: Cetuximab + chemoradiation (63 Gy/35 fractions/7 weeks) with weekly carboplatin + paclitaxel
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: FISH-positive disease
Number of subjects: 87
Study: 22750403

Group type: EXPERIMENTAL
Intervention: Risedronate 35mg once a week for 4 years
Number of subjects: 218

Group type: COMPARATOR
Intervention: Risedronate 35mg once a week for 2 years (former placebo group)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Risedronate 35mg once a week for 2 years
Number of subjects: 218
Study: 19967577

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (CBGT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No-treatment wait-list control
Number of subjects: 150
Study: 17387227

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (education session)
Number of subjects: 60
Study: 17327307

Group type: EXPERIMENTAL
Intervention: Metformin (1 g b.d.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Higher-dose oral contraceptive (OCP) 35 microg ethinyl estradiol [EE]/2 mg cyproterone acetate
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose OCP (20 microg EE/100 microg levonorgestrel + aldactone 50 mg b.d.)
Number of subjects: 100
Study: 15116060

Group type: EXPERIMENTAL
Intervention: Simvastatin, 80 mg/d
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 10740327

Group type: EXPERIMENTAL
Intervention: Leuprorelin acetate
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8608881

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily after H. pylori eradication
Number of subjects: 33

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily before H. pylori eradication
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Baseline intragastric pH before and after H. pylori eradication
Number of subjects: 33
Study: 15374410

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 80 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2931964

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg t.i.d. for 3 months)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ketanserin (subacute treatment)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 31588356

Group type: EXPERIMENTAL
Intervention: Electroencephalography guided anesthesia
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Standard anesthetic practice
Number of subjects: 1200
Study: 29051176

Group type: EXPERIMENTAL
Intervention: Co-located welfare advice
Number of subjects: 17
Study: 25373688

Group type: EXPERIMENTAL
Intervention: LLLT irradiation (test group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: LLLT sham (control group)
Number of subjects: 32
Study: 23392075

Group type: EXPERIMENTAL
Intervention: Bendamustine with 500 mL of diluent
Number of subjects: 43

Group type: COMPARATOR
Intervention: Bendamustine with 250 mL of diluent
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bendamustine concentration ≤0.40 mg/mL
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bendamustine concentration 0.41-0.60 mg/mL
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bendamustine concentration >0.60 mg/mL
Number of subjects: 43
Study: 21472754

Group type: EXPERIMENTAL
Intervention: Psychotherapy designed to alter non-weight related self-cognitions
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 69
Study: 19325050

Group type: EXPERIMENTAL
Intervention: Oil-on-top treatment (OT): 4 g of high-oleic-acid rapeseed oil (4.6 ml, 36 kcal) infused after a fat-free liquid meal (LM, 325 ml, 145 kcal)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Emulsion treatment (EM): 4 g of labeled rapeseed oil incorporated into LM (325 ml, 181 kcal); 4.6 ml of saline infused as control
Number of subjects: 6
Study: 17229483

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF)
Number of subjects: 86

Group type: COMPARATOR
Intervention: SPA therapy (ST)
Number of subjects: 86
Study: 15041619

Group type: EXPERIMENTAL
Intervention: 0.5 mA
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.9 mA
Number of subjects: 59
Study: 11344395

Group type: EXPERIMENTAL
Intervention: Locally available, inexpensive market soap and methylated spirit
Number of subjects: 200

Group type: COMPARATOR
Intervention: Imported Povidone-iodine (PI)
Number of subjects: 200
Study: 9149172

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer therapy with fast inhalation at a respiratory rate of 36 breaths/minute and intermittent vocalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer therapy with fast inhalation at a respiratory rate of 36 breaths/minute
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrasonic nebulizer therapy with deep and slow inhalation at a respiratory rate of 12 breaths/minute
Number of subjects: 0
Study: 8120152

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 153
Study: 3661285

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 0
Study: 31848062

Group type: EXPERIMENTAL
Intervention: Inhaled N-acetylcysteine (NAC) with oral rabeprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral rabeprazole
Number of subjects: 0
Study: 31618774

Group type: EXPERIMENTAL
Intervention: Positive-profile threaded ESF pins placed without predrilling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Positive-profile threaded ESF pins placed with predrilling
Number of subjects: 20
Study: 30137481

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 100
Study: 27114389

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) during year 1
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Insulin users in ILI
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Non-insulin users in ILI
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) participants in upper 50% of weight loss
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) participants in lower 50% of weight loss
Number of subjects: 5145
Study: 25081493

Group type: EXPERIMENTAL
Intervention: RandAL method for aligning DNA sequences to reference genomes
Number of subjects: 0
Study: 22735384

Group type: EXPERIMENTAL
Intervention: Dabrafenib (150 mg twice daily, orally)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Dacarbazine (1000 mg/m(2) intravenously every 3 weeks)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Dabrafenib
Number of subjects: 250

Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 250
Study: 20721651

Group type: EXPERIMENTAL
Intervention: Probiotic bacterial formulation (90 billion CFUs/day)
Number of subjects: 46
Study: 18796263

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (fundoplication)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Continued medical management
Number of subjects: 810
Study: 15629973

Group type: EXPERIMENTAL
Intervention: Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged
Number of subjects: 367

Group type: COMPARATOR
Intervention: Breast milk alone
Number of subjects: 367
Study: 11956264

Group type: EXPERIMENTAL
Intervention: Sequential biochemotherapy (CVD + interleukin‐2 + interferon alfa‐2b)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Chemotherapy (CVD)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Sequential biochemotherapy
Number of subjects: 190

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 190
Study: 9607475

Group type: EXPERIMENTAL
Intervention: Antibiotics and urokinase (5,000 U boluses at 12 and 24 hours)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 63
Study: 8537865

Group type: EXPERIMENTAL
Intervention: Collagen membrane plus DFDBA
Number of subjects: 10

Group type: COMPARATOR
Intervention: Collagen membrane only
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison between test and control groups
Number of subjects: 10
Study: 2375296

Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (14 g/d, 55% n-3 fatty acids)
Number of subjects: 64
Study: 704653

Group type: COMPARATOR
Intervention: d-amphetamine 15 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: d-amphetamine 5-20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: d-amphetamine
Number of subjects: 8
Study: 31382299

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 98

Group type: COMPARATOR
Intervention: All steroids
Number of subjects: 98
Study: 30990367

Group type: COMPARATOR
Intervention: IMRRP-2 (2-minute inter maximal-repetition rest period)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: IMRRP-3 (3-minute inter maximal-repetition rest period)
Number of subjects: 9
Study: 29106311

Group type: EXPERIMENTAL
Intervention: Bihormonal bionic pancreas (BP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 39
Study: 24557411

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical (MIS) approach
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional approach (anterolateral modified Watson‐Jones)
Number of subjects: 90
Study: 23635331

Group type: EXPERIMENTAL
Intervention: Mobile phone self-management support intervention
Number of subjects: 480

Group type: COMPARATOR
Intervention: Usual care in the existing programme
Number of subjects: 480
Study: 22137078

Group type: EXPERIMENTAL
Intervention: Dyn TMP 2/3
Number of subjects: 3267

Group type: EXPERIMENTAL
Intervention: Den TMP 2/3
Number of subjects: 3267

Group type: COMPARATOR
Intervention: TMP 0/1
Number of subjects: 3267
Study: 18203683

Group type: COMPARATOR
Intervention: School-based HIV prevention programme (control arm of a cluster-randomized controlled trial)
Number of subjects: 2360
Study: 17116511

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptive containing norgestimate (NGM) 180-250 microg and ethinyl estradiol (EE) 35 microg
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 15375469

Group type: EXPERIMENTAL
Intervention: Surgical valvular treatment associated with isolation of the left atrial posterior wall (treated group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Surgical valvular treatment (control group)
Number of subjects: 29
Study: 11719726

Group type: EXPERIMENTAL
Intervention: Ritonavir (600 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9127159

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (200 micrograms)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 1337465

Group type: EXPERIMENTAL
Intervention: DPE (doxorubicin, cisplatin and etoposide)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CIV (carboplatin, ifosfamide and vincristine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DPE
Number of subjects: 60

Group type: COMPARATOR
Intervention: CIV
Number of subjects: 60
Study: 3927932

Group type: EXPERIMENTAL
Intervention: Selegiline (Eldepryl)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fenetylline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chlorphenoxamine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31393354

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 48
Study: 29133014

Group type: EXPERIMENTAL
Intervention: BrECAPP (brentuximab vedotin 1.8 mg/kg on day 1, etoposide 200 mg/m2 on days 2-4, doxorubicin 35 mg/m2 on day 2, cyclophosphamide 1250 mg/m2 on day 2, procarbazine 100 mg/m2 on days 2-8, and prednisone 40 mg/m2 on days 2-15)
Number of subjects: 104

Group type: COMPARATOR
Intervention: BrECADD (brentuximab vedotin 1.8 mg/kg on day 1, etoposide 150 mg/m2 on days 2-4, doxorubicin 40 mg/m2 on day 2, cyclophosphamide 1250 mg/m2 on day 2, dacarbazine 250 mg/m2 on days 3-4, and dexamethasone 40 mg on days 2-5)
Number of subjects: 104
Study: 25415628

Group type: EXPERIMENTAL
Intervention: Low-dose succinylcholine (0.5 mg/kg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Low-dose rocuronium with sugammadex (0.25 mg/kg and 0.5 mg/kg respectively)
Number of subjects: 95
Study: 23418822

Group type: EXPERIMENTAL
Intervention: New amino acid-based formula (Sineall, Humana, Milan, Italy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Validated amino acid-based formula (placebo)
Number of subjects: 60
Study: 21791080

Group type: EXPERIMENTAL
Intervention: Tutorial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tutorial + Practice Exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: AGREE II User's Manual PDF (control condition)
Number of subjects: 0
Study: 17913794

Group type: EXPERIMENTAL
Intervention: Trimethoprim (160 mg twice daily for 6 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16927766

Group type: EXPERIMENTAL
Intervention: Short wavelength automated perimetry (SWAP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard automated perimetry (SAP)
Number of subjects: 55
Study: 12605721

Group type: EXPERIMENTAL
Intervention: Matching pursuit algorithm for time-frequency analysis of EEG
Number of subjects: 0
Study: 10781122

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask tracheal tube
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard tracheal tube
Number of subjects: 36
Study: 8836757

Group type: EXPERIMENTAL
Intervention: Low dose diltiazem (1 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High dose diltiazem (2 or 3 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Inactive placebo (control group)
Number of subjects: 38
Study: 1442572

Group type: EXPERIMENTAL
Intervention: 30 mg/day of isosorbide dinitrate (ISDN)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 60 mg/day of isosorbide dinitrate (ISDN)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mg/day of transdermal nitrate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg/day of transdermal nitrate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3914178

Group type: EXPERIMENTAL
Intervention: Arbaprostil 10 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Arbaprostil 25 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Arbaprostil 50 micrograms
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (0 micrograms)
Number of subjects: 8
Study: 3524473

Group type: EXPERIMENTAL
Intervention: Nebulised ribavirin (14 infants)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal saline aerosol (12 infants)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nebulised ribavirin (20 infants with RSV identified)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal saline aerosol (20 infants with RSV identified)
Number of subjects: 26
Study: 31851982

Group type: EXPERIMENTAL
Intervention: High-volume hemodiafiltration (HDF)
Number of subjects: 197

Group type: COMPARATOR
Intervention: High flux hemodialysis (HD)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: 1st shift dialysis
Number of subjects: 197
Study: 30537951

Group type: EXPERIMENTAL
Intervention: AOI of 5 L/min oxygen on the non-ventilated lung immediately at the beginning of OLV
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional OLV mode
Number of subjects: 54
Study: 28590362

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 24107257

Group type: EXPERIMENTAL
Intervention: Topical administration of a 3% clodronate solution mixed with Tween-20 at a 1:3 ratio
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional implant procedure (control side)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Topical administration of a 3% clodronate solution
Number of subjects: 39
Study: 24211360

Group type: EXPERIMENTAL
Intervention: Healthful diet intervention with dietary advice aimed at meeting nutritional requirements
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1250
Study: 21178592

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 11
Study: 18326593

Group type: EXPERIMENTAL
Intervention: Very-low-carbohydrate, high-saturated-fat weight-loss diet (LC)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Isocaloric high-carbohydrate, low-saturated-fat diet (HC)
Number of subjects: 99
Study: 16599649

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 14555365

Group type: EXPERIMENTAL
Intervention: Treatment A (enriched stimulus environment, collaborative multidisciplinary interventions, additional yes/no response training)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Treatment B (standard hospital environment and interventions)
Number of subjects: 13
Study: 11099571

Group type: EXPERIMENTAL
Intervention: Written oral hygiene instruction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Videotape oral hygiene instruction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: One-to-one instruction by a hygienist
Number of subjects: 65
Study: 8881789

Group type: EXPERIMENTAL
Intervention: pH adjusted lignocaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: commercial lignocaine
Number of subjects: 40
Study: 1576626

Group type: EXPERIMENTAL
Intervention: Loracarbef 200 mg once daily for 7 days
Number of subjects: 333

Group type: COMPARATOR
Intervention: Cefaclor 250 mg thrice daily for 7 days
Number of subjects: 333
Study: 4048810

Group type: COMPARATOR
Intervention: Oral ketoprofen (2 x 50 mg) administered at 7:00 a.m., 1:00 p.m., 7:00 p.m., and 1:00 a.m.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of ketoprofen (5 mg/kg/day) over 24 hours
Number of subjects: 16
Study: 31519496

Group type: EXPERIMENTAL
Intervention: Video-based decision aid
Number of subjects: 97

Group type: COMPARATOR
Intervention: Avatar-based decision aid
Number of subjects: 97
Study: 28049699

Group type: EXPERIMENTAL
Intervention: SBP <130 mm Hg
Number of subjects: 3035

Group type: COMPARATOR
Intervention: SBP 130 to <145 mm Hg (reference group)
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: SBP ≥145 mm Hg
Number of subjects: 3035
Study: 25218328

Group type: EXPERIMENTAL
Intervention: Standard technique (14 patients)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tissue preservation technique (15 patients)
Number of subjects: 29
Study: 24088805

Group type: EXPERIMENTAL
Intervention: Sincronil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topamax
Number of subjects: 60
Study: 21131307

Group type: EXPERIMENTAL
Intervention: Gonorrhoea dacron‐tipped swab
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Chlamydia rayon‐tipped swab
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Plastic 10 μl urethral loop
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: First swab (any type)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Second swab (any type)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Third swab (any type)
Number of subjects: 121
Study: 19131659

Group type: EXPERIMENTAL
Intervention: OCSP syndrome classification
Number of subjects: 510
Study: 17195085

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 168

Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 168
Study: 15519449

Group type: EXPERIMENTAL
Intervention: Assertiveness training program (eight 2-hour sessions once a week)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69